Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Tony van Werkhooven who wrote (1273)	3/10/1998 9:03:00 AM
From: Premier	Respond to of 2068

Towrds the end of the article this paragraph appeared "The issue of the individual plans is also complicated for Oxford because the company is, in a sense, caught between two constituencies. On one hand, it is eager to demonstrate to Wall Street that it will focus on profitable products and will deemphasize less remunerative government business like Medicare and Medicaid. At the same time, Oxford is required by state law to provide insurance to individuals, and so its losses are largely a matter of how much of an increase and how much of a subsidy state regulators approve" Since the author included medicare and medicaid in the same context, I may have mistakenly interpreted. "Less remunerative" does not mean loosing line I guess. My understanding was that medicare was profitable business. Why would then Oxford deemphasize medicare? Thanks. Premier